Bill and Melinda Gates Foundation donations made to GlaxoSmithKline Biologicals

This is an online portal with information on donations that were announced publicly (or have been shared with permission) that were of interest to Vipul Naik. The git repository with the code for this portal, as well as all the underlying data, is available on GitHub. All payment amounts are in current United States dollars (USD). The repository of donations is being seeded with an initial collation by Issa Rice as well as continued contributions from him (see his commits and the contract work page listing all financially compensated contributions to the site) but all responsibility for errors and inaccuracies belongs to Vipul Naik. Current data is preliminary and has not been completely vetted and normalized; if sharing a link to this site or any page on this site, please include the caveat that the data is preliminary (if you want to share without including caveats, please check with Vipul Naik). We expect to have completed the first round of development by the end of December 2019. See the about page for more details. Also of interest: pageview data on analytics.vipulnaik.com, tutorial in README, request for feedback to EA Forum.

Table of contents

Basic donor information

ItemValue
Country United States
Wikipedia pagehttps://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation
Best overview URLhttps://en.wikipedia.org/wiki/Bill_%26_Melinda_Gates_Foundation
Facebook username gatesfoundation
LinkedIn username bill-&-melinda-gates-foundation
Websitehttps://www.gatesfoundation.org/
Donations URLhttps://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database
Twitter usernamegatesfoundation
Page on philosophy informing donationshttps://www.gatesfoundation.org/What-We-Do
Grant application process pagehttps://www.gatesfoundation.org/How-We-Work/General-Information/Grantseeker-FAQ
Regularity with which donor updates donations datacontinuous updates
Regularity with which Donations List Website updates donations data (after donor update)irregular
Lag with which donor updates donations datamonths
Lag with which Donations List Website updates donations data (after donor update)years
Data entry method on Donations List WebsiteSQL insertion commands generated by script https://github.com/riceissa/gates-foundation-iati-processing

Brief history: The Gates Foundation launched in 2000, with precursors starting in the 1990s, financed by the personal wealth of co-founder Bill Gates from Microsoft. Starting 2005, it scaled up its giving significantly after a large funding commitment from Warren Buffett

Brief notes on broad donor philosophy and major focus areas: See https://www.gatesfoundation.org/Who-We-Are/General-Information/Foundation-Factsheet for the grantmaking areas. The four grantmaking areas are the Global Development Program, Global Health Program, Global Policy and Advocacy, and United States Program. Within the United States Program the focus is on K-12 education, the Internet, and emergency relief

Notes on grant publication logistics: Although the Gates Foundation has a grants database on its website, as well as individual grant pages for every grant, we use the IATI data instead, because it can be processed programmatically (the data on the site does not allow for full data download or easy programmatic processing). This leads to a few problems: first, IATI data does not include grants made in the United States, since it focuses on development assistance (DA) spending. Second, IATI data is updated more infrequently. Third, it may sometimes omit some information that is present in the grants database

Full donor page for donor Bill and Melinda Gates Foundation

Basic donee information

ItemValue
Country

Full donee page for donee GlaxoSmithKline Biologicals

Donation amounts by cause area and year

If you hover over a cell for a given cause area and year, you will get a tooltip with the number of donees and the number of donations.

Note: Cause area classification used here may not match that used by donor for all cases.

Cause area Number of donations Total 2017 2016 2015 2014 2012 2011
Global health (filter this donor) 12 43,927,794.00 -791,398.00 -1,670,917.00 16,391,849.00 12,351,827.00 2,890,159.00 14,756,274.00
Total 12 43,927,794.00 -791,398.00 -1,670,917.00 16,391,849.00 12,351,827.00 2,890,159.00 14,756,274.00

Graph of spending by cause area and year (incremental, not cumulative)

Graph of spending should have loaded here

Graph of spending by cause area and year (cumulative)

Graph of spending should have loaded here

Full list of donations in reverse chronological order (12 donations)

Amount (current USD)Donation dateCause areaURLInfluencerNotes
-791,398.002017-04-25Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to support the development of the cell line for manufacturing of a pilot lot of gp120 Clade B/E protein for a Phase I bridging study; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
-952,386.002016-06-30Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to accelerate Ebola Vaccine Production and Development order to treat those affected by the Ebola epidemic in West Africa; Aid type: Project-type interventions. Affected regions: Africa.
-718,531.002016-06-01Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to accelerate Ebola Vaccine Production and Development order to treat those affected by the Ebola epidemic in West Africa; Aid type: Project-type interventions. Affected regions: Africa.
15,100,417.002015-12-10Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to develop a multivalent Shigella vaccine focused on the needs of developing countries where Shigellosis is a public health concern; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
645,716.002015-01-22Global health/malariahttps://iatiregistry.org/publisher/bmgf-- to provide a new dimension to vaccine development for malaria and tuberculosis (TB) by deeper analysis of transcriptomics data that are being generated in clinical studies, by promoting collaboration between different partners involved in Systems Biology ; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
645,716.002015-01-22Global health/Tuberculosis controlhttps://iatiregistry.org/publisher/bmgf-- to provide a new dimension to vaccine development for malaria and tuberculosis (TB) by deeper analysis of transcriptomics data that are being generated in clinical studies, by promoting collaboration between different partners involved in Systems Biology ; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
2,200,000.002014-12-03Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to manufacture clinical lots of HIV proteins for efficacy evaluation of poxvirus/protein prime-boost regimes in Southern Africa; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
1,199,441.002014-11-25Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to accelerate the development of new vaccines for high priority diseases such as malaria, tuberculosis (TB), and HIV by permitting external investigators access to Adjuvant Systems that have been properly formulated and thus “optimized” for successful pre; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
6,000,000.002014-11-07Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to fund epidemiological and clinical endpoint definition studies in support of adjuvanted purified and inactivated vaccine development; Aid type: Project-type interventions. Affected regions: South America|South & Central Asia.
2,952,386.002014-10-14Global health/infectious disease controlhttps://iatiregistry.org/publisher/bmgf-- to accelerate Ebola Vaccine Production and Development order to treat those affected by the Ebola epidemic in West Africa; Aid type: Project-type interventions. Affected regions: Africa.
2,890,159.002012-11-09Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to support the development of the cell line for manufacturing of a pilot lot of gp120 Clade B/E protein for a Phase I bridging study; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.
14,756,274.002011-11-21Global health/STD control including HIV/AIDShttps://iatiregistry.org/publisher/bmgf-- to manufacture clinical lots of HIV proteins for efficacy evaluation of poxvirus/protein prime-boost regimes in Southern Africa; Aid type: Project-type interventions. Affected regions: Developing countries, unspecified.